Figure 5.
IL1B treatment trends with molQTLs and motif mutations. (A) Diagram of treatment design and Venn diagram of SNPs that validated in untreated (left), IL1B-treated for 6 h (right), and IL1B-treated for 24 h (bottom). (B) Heat map of enrichment scores comparing SNPs uniquely in specific treatment conditions between STARR-seq and the molQTLs (i.e., SNPs only significant in STARR-seq 0-h and not in 6-h or 24-h IL1B-treated). (C) Heat map of enrichment scores comparing SNPs uniquely in specific treatment conditions between STARR-seq and the motif mutations.
